Trial of Acyclovir and Corticosteroids for Herpes Encephalitis
Author Information
Author(s): Francisco Martinez-Torres, Sanjay Menon, Maria Pritsch, Norbert Victor, Ekkehart Jenetzky, Katrin Jensen, Eva Schielke, Erich Schmutzhard, Jan de Gans, Chin-Hee Chung, Steffen Luntz, Werner Hacke, Uta Meyding-Lamadé
Primary Institution: Department of Neurology, University of Heidelberg, Germany
Hypothesis
Does the addition of adjuvant dexamethasone to acyclovir improve outcomes in patients with herpes-simplex-virus-encephalitis?
Conclusion
The study aims to determine if adding dexamethasone to acyclovir treatment improves outcomes for patients with herpes-simplex-virus-encephalitis.
Supporting Evidence
- Current treatment for herpes-simplex-virus-encephalitis is acyclovir, but outcomes remain poor.
- Adjuvant corticosteroids may improve outcomes based on previous studies.
- The trial aims to provide evidence for the routine use of corticosteroids in this condition.
Takeaway
Doctors are testing if giving a steroid called dexamethasone along with a medicine called acyclovir can help people who are very sick from a virus in their brain.
Methodology
This is a multicenter, randomized, double-blind, placebo-controlled trial comparing acyclovir with and without dexamethasone in adults with herpes-simplex-virus-encephalitis.
Potential Biases
Potential biases may arise from the double-blind design and the reliance on patient consent.
Limitations
The study may face challenges in recruitment and adherence to the protocol due to the complexity of the condition and treatment.
Participant Demographics
Adults aged 18 to 85 with confirmed herpes-simplex-virus-encephalitis.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website